offline
Pfizer Reports Mixed Q4 Earnings
Pfizer (NYSE: PFE) reported adjusted fourth-quarterly earnings of 55 cents per share on Tuesday, which missed the analyst consensus estimate of 57 cents by 3.51%. This is a 14.06% decrease over earnings of 64 cents per share from the same period last year.
The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion by 0.71%. This is a 9.13% decrease over sales of $13.976 billion the same period last year.
Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.
...
https://finance.yahoo.com/news/pfizer-re...15239.html
![[Bild: PFEc1dl1515.png]](https://finviz.com/publish/012820/PFEc1dl1515.png)
Pfizer (NYSE: PFE) reported adjusted fourth-quarterly earnings of 55 cents per share on Tuesday, which missed the analyst consensus estimate of 57 cents by 3.51%. This is a 14.06% decrease over earnings of 64 cents per share from the same period last year.
The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion by 0.71%. This is a 9.13% decrease over sales of $13.976 billion the same period last year.
Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.
...
https://finance.yahoo.com/news/pfizer-re...15239.html
__________________
